Poolsup Nalinee, Suksomboon Naeti, Amin Muhammad
Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon-Pathom, Thailand.
Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
PLoS One. 2014 Mar 21;9(3):e92485. doi: 10.1371/journal.pone.0092485. eCollection 2014.
To assess the efficacy and safety of treating pregnant women with gestational diabetes mellitus in comparison to usual antenatal care.
A systematic review and meta-analysis was conducted by including randomized controlled trials comparing any form of therapeutic intervention in comparison to usual antenatal care. A literature search was conducted using electronic databases together with a hand search of relevant journals and conference proceedings.
Ten studies involving 3,881 patients contributed to meta-analysis. Our results indicated that gestational diabetes mellitus treatment significantly reduced the risk for macrosomia (RR, 0.47; 95% CI, 0.38-0.57), large for gestational age births (RR, 0.55; 95% CI, 0.45-0.67), shoulder dystocia (RR, 0.42; 95% CI, 0.23-0.77) and gestational hypertension (RR, 0.68; 95% CI, 0.53-0.87) without causing any significant increase in the risk for small for gestational age babies. However, no significant difference was observed between the two groups regarding perinatal/neonatal mortality, neonatal hypoglycemia, birth trauma, preterm births, pre-eclampsia, caesarean section and labor induction.
Treating GDM reduces risk for many important adverse pregnancy outcomes and its association with any harm seems unlikely.
评估与常规产前护理相比,治疗妊娠期糖尿病孕妇的疗效和安全性。
通过纳入比较任何形式的治疗干预与常规产前护理的随机对照试验进行系统评价和荟萃分析。使用电子数据库进行文献检索,并手动检索相关期刊和会议论文集。
10项涉及3881名患者的研究纳入荟萃分析。我们的结果表明,妊娠期糖尿病治疗显著降低了巨大儿风险(RR,0.47;95%CI,0.38 - 0.57)、大于胎龄儿出生风险(RR,0.55;95%CI,0.45 - 0.67)、肩难产风险(RR,0.42;95%CI,0.23 - 0.77)和妊娠期高血压风险(RR,0.68;95%CI,0.53 - 0.87),且未导致小于胎龄儿风险显著增加。然而,两组在围产期/新生儿死亡率、新生儿低血糖、产伤、早产、子痫前期、剖宫产和引产方面未观察到显著差异。
治疗妊娠期糖尿病可降低许多重要不良妊娠结局的风险,且似乎不太可能与任何危害相关。